{"id":378016,"date":"2024-05-22T14:00:00","date_gmt":"2024-05-22T12:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=378016"},"modified":"2024-05-22T14:00:00","modified_gmt":"2024-05-22T12:00:00","slug":"il-doppio-agonista-del-recettore-gip-glp-1-come-opzione-terapeutica-innovativa","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/it\/il-doppio-agonista-del-recettore-gip-glp-1-come-opzione-terapeutica-innovativa\/","title":{"rendered":"Il doppio agonista del recettore GIP\/GLP-1 come opzione terapeutica innovativa"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":7,"featured_media":126779,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Diabete di tipo 2: tendenze attuali  ","footnotes":""},"category":[11392,11519,11306,11550,11515],"tags":[75339,12013,23774,19664,75340,75338,75337,75336,69633,74888],"powerkit_post_featured":[],"class_list":["post-378016","post","type-post","status-publish","format-standard","has-post-thumbnail","category-endocrinologia-e-diabetologia","category-formazione-continua","category-medicina-interna-generale","category-rx-it","category-studi","tag-agonista-doppio-del-recettore-gip-glp-1","tag-diabete-di-tipo-2-it","tag-gip-it","tag-glp-1-it","tag-mounjaro-it","tag-opzione-terapeutica-innovativa","tag-peptide-insulinotropico-dipendente-dal-glucosio","tag-peptide-simile-al-glucagone","tag-surpass-it","tag-terapie-basate-sullincretina","pmpro-has-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-17 13:47:10","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"it_IT","wpml_translations":{"pt_PT":{"locale":"pt_PT","id":378031,"slug":"agonista-duplo-do-recetor-gip-glp-1-como-opcao-terapeutica-inovadora","post_title":"Agonista duplo do recetor GIP\/GLP-1 como op\u00e7\u00e3o terap\u00eautica inovadora","href":"https:\/\/medizinonline.com\/pt-pt\/agonista-duplo-do-recetor-gip-glp-1-como-opcao-terapeutica-inovadora\/"},"es_ES":{"locale":"es_ES","id":377975,"slug":"agonista-dual-de-los-receptores-gip-glp-1-como-opcion-terapeutica-innovadora","post_title":"Agonista dual de los receptores GIP\/GLP-1 como opci\u00f3n terap\u00e9utica innovadora","href":"https:\/\/medizinonline.com\/es\/agonista-dual-de-los-receptores-gip-glp-1-como-opcion-terapeutica-innovadora\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/378016","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/comments?post=378016"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/378016\/revisions"}],"predecessor-version":[{"id":379621,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/378016\/revisions\/379621"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media\/126779"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media?parent=378016"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/category?post=378016"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/tags?post=378016"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/powerkit_post_featured?post=378016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}